Neuronetics, Inc. Common Stock (STIM) Stock Price

STIMStock

$1.89−34.55%52W

Market Cap$143.63M

P/E—

PEG Ratio—

Div yield—

Beta1.34

STIM Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)21.91%

Price vs S&P 500 (4W)-32.53%

VGM Score63.82

Book Value / Share (Quarterly)$0.23

P/TBV (Annual)22.35x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)31.76%

Cash Flow / Share (Quarterly)$-0.15

Price vs S&P 500 (YTD)24.67%

Gross Margin (TTM)49.12%

Net Profit Margin (TTM)-19.62%

EPS (TTM)$-0.44

10-Day Avg Trading Volume0.69M

EPS Excl Extra (TTM)$-0.44

Revenue Growth (5Y)24.81%

EPS (Annual)$-0.59

ROI (Annual)-44.22%

Gross Margin (Annual)48.48%

Net Profit Margin (5Y Avg)-48.04%

Cash / Share (Quarterly)$0.25

Revenue Growth QoQ (YoY)9.08%

ROA (Last FY)-27.55%

Revenue Growth TTM (YoY)39.59%

EBITD / Share (TTM)$-0.29

ROE (5Y Avg)-104.40%

Operating Margin (TTM)-15.09%

Cash Flow / Share (Annual)$-0.31

P/B Ratio8.05x

P/B Ratio (Quarterly)5.07x

Net Income / Employee (Annual)$-59,300

EV / Revenue (TTM)1.20x

Net Interest Coverage (TTM)-3.65x

ROA (TTM)-22.38%

EPS Incl Extra (Annual)$-0.59

Current Ratio (Annual)2.02x

Quick Ratio (Quarterly)1.46x

3-Month Avg Trading Volume1.80M

52-Week Price Return-34.55%

Revenue / Employee (TTM)$235,700

Tangible BV / Share (Quarterly)$0.01

P/S Ratio (Annual)0.96x

Asset Turnover (Annual)1.05x

52-Week High$3.44

Operating Margin (5Y Avg)-43.93%

EPS Excl Extra (Annual)$-0.59

CapEx CAGR (5Y)1.87%

26-Week Price Return31.82%

Quick Ratio (Annual)1.68x

13-Week Price Return16.36%

Total Debt / Equity (Annual)2.94x

Current Ratio (Quarterly)1.88x

Enterprise Value$185.95M

Revenue / Share Growth (5Y)-2.85%

Asset Turnover (TTM)1.14x

Book Value / Share Growth (5Y)-24.65%

Revenue / Employee (Annual)$226,700

Inventory Turnover (Annual)17.92x

Pretax Margin (Annual)-26.24%

Cash / Share (Annual)$0.41

3-Month Return Std Dev125.15%

Gross Margin (5Y Avg)69.69%

Net Income / Employee (TTM)$-46,200

ROE (Last FY)-174.27%

Net Interest Coverage (Annual)-2.46x

EPS Basic Excl Extra (Annual)$-0.59

Receivables Turnover (TTM)7.37x

Total Debt / Equity (Quarterly)3.45x

EPS Incl Extra (TTM)$-0.44

Receivables Turnover (Annual)7.49x

ROI (TTM)-36.32%

P/S Ratio (TTM)0.93x

Pretax Margin (5Y Avg)-48.06%

Revenue / Share (Annual)$2.26

Tangible BV / Share (Annual)$0.06

Price vs S&P 500 (52W)-50.08%

Year-to-Date Return36.59%

5-Day Price Return-11.50%

EPS Normalized (Annual)$-0.59

ROA (5Y Avg)-27.70%

Net Profit Margin (Annual)-26.15%

Month-to-Date Return-19.44%

Cash Flow / Share (TTM)$-1.10

EBITD / Share (Annual)$-0.42

Operating Margin (Annual)-21.08%

LT Debt / Equity (Annual)2.94x

ROI (5Y Avg)-39.01%

LT Debt / Equity (Quarterly)3.45x

EPS Basic Excl Extra (TTM)$-0.44

P/TBV (Quarterly)210.38x

P/B Ratio (Annual)4.22x

Inventory Turnover (TTM)15.11x

Pretax Margin (TTM)-19.89%

Book Value / Share (Annual)$0.32

Price vs S&P 500 (13W)13.67%

Beta1.34x

Revenue / Share (TTM)$2.12

ROE (TTM)-150.56%

52-Week Low$0.80

vGradeB

gGradeB

mGradeC

vgmGradeB

STIM Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 11, 2026	-$0.12	-$0.04	+65.10%(+$0.08)
Q1 2026	May 5, 2026	-$0.17	-$0.15	+15.02%(+$0.03)
Q4 2025	Mar 17, 2026	-$0.11	-$0.10	+9.09%(+$0.01)
Q3 2025	Nov 4, 2025	-$0.12	-$0.13	-8.33%(-$0.01)
Q2 2025	Aug 5, 2025	-$0.08	-$0.15	-87.50%(-$0.07)

STIM Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.11

4.20

4.22

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
STIMNeuronetics, Inc. Common Stock	B	B	C	0.9x	24.8%	49.1%	-15.1%	$1.89
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Neuronetics, Inc. Common Stock

Neuronetics Inc is a medical device company specializing in transcranial magnetic stimulation (TMS) therapy for psychiatric disorders. Its flagship product, the NeuroStar Advanced Therapy System, is a non-invasive, office-based treatment that uses MRI-strength magnetic fields to stimulate brain regions associated with mood regulation. NeuroStar is approved to treat major depressive disorder (MDD) and offers an alternative to conventional psychiatric therapies that may have significant side effects or efficacy limitations.

STIM Next Earnings Report

Report dateNov 3, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate-$0.11

Revenue estimate$40.42M

Also reporting on Nov 3, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

STIM Insider Transactions

BuyAug 14, 2026
CHERNETT JOREY
Beneficial Owner of more than 10% of a Class of Security
Shares: 14,000Value: $44,240

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for August 2026

Companies in Related Industries

RXSTRxSight, Inc. Common StockOphthalmic Goods
INGNInogen IncOrthopedic & Prosthetic Devices
INTTinTEST CorporationInstruments for Measuring
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary SharesOrthopedic & Prosthetic Devices
HURCHurco Cos IncIndustrial Instruments
QTRXQuanterix Corporation Common StockLab Analytical Instruments
OWLTOwlet, Inc.Measuring & Controlling Devices
SEERSeer, Inc. Class A Common StockLab Analytical Instruments

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.2

Strong Buy

Consensus rating

52-Week Range

Low$0.80

High$3.44